A CDER Regulatory Science Impact Story describes Center researchers efforts to develop microengineering human cellular system to predict drug toxicity...
FDA expands its RCT DUPLICATE demonstration project to use real-world evidence to estimate results of seven Phase 4 trials.
FDA denies a Helius Medical Technologies de novo marketing request for its Portable Neuromodulation Stimulator device for treating patients with chron...
FDA clears a Bedfont 510(k) for its ToxCO carbon monoxide (CO) breath analysis monitor which determines levels of carbon monoxide poisoning.
The Federal Trade Commission says corporate and individual defendants have resolved cognitive improvement supplement deceptive marketing charges.
FDA cautions against using unapproved or uncleared medical devices to diagnose, treat, or manage head injuries, including concussions.
A federal grand jury indicts Invidior for illegal misleading marketing of its Suboxone Film opioid-addiction treatment.
Braeburn asks FDA to revoke the orphan drug designation for Invidiors opioid use disorder drug Sublocade.